|
JP2019189569A
|
|
Phosphine compound, crosslinked composition, and manufacturing method of aromatic amine compound
|
|
JP2018162221A
|
|
Arylpyrrolidine dicarboxylic acid amide derivative
|
|
JP2015137253A
|
|
Fluorine-containing carboxylic acid derivatives
|
|
WO2012144551A1
|
|
Silicon-containing carboxylic acid derivative
|
|
CN102131811A
|
|
Oxazolidinone derivative having fused ring
|
|
WO2009107762A1
|
|
Aromatic amide derivative
|
|
CN101855199A
|
|
Tricyclic amide compound
|
|
WO2009022722A1
|
|
Tricyclic amine compound
|
|
CN101821236A
|
|
Five-membered heterocyclic compound
|
|
AU2007360907A1
|
|
Retinoid prodrug compound
|
|
WO2007116960A1
|
|
Oxazolidinone derivative having carbocyclic ring
|
|
EP2181993A1
|
|
Antimicrobial oxazolidinone derivatives
|
|
JP2008094727A
|
|
Retinoid prodrug compound
|
|
US2007049579A1
|
|
Medicament having neovascularization promoting action
|
|
JP2007145723A
|
|
Ureido tropolone derivative
|
|
US2007265277A1
|
|
Serotonin 5-HT3 receptor agonist
|
|
WO2005087219A1
|
|
Memory fixation accelerator
|
|
EP1612264A1
|
|
Organ-forming method
|
|
JP2005239631A
|
|
Medicine having vascularization-promoting action
|
|
CN1655816A
|
|
The medicine that is used for the vascular conditions treatment
|
